Showing results (671-680 of 689) with videos related to

Sort By:
Pageof 69
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
Plos Genetics|May 3, 2011
Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture riskEmma L Duncan, Patrick Danoy, John P Kemp, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Human Molecular Genetics|November 20, 2013
Multistage genome-wide association meta-analyses identified two new loci for bone mineral densityLei Zhang, Hyung Jin Choi, Karol Estrada, et al.
Plos Genetics|July 14, 2012
WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture riskHou-Feng Zheng, Jon H Tobias, Emma Duncan, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Pageof 69